(Q40311131)

English

Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness

scientific article published on 21 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

West Nile virus

0 references

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Alan D T Barrett

6

object named as

Alan D T Barrett

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Melissa C Whiteman

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Jason A Wicker

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Richard M Kinney

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Claire Y-H Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

21 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

9702-9710

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

The continuing spread of West Nile virus in the western hemisphere

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Virology, pathology, and clinical manifestations of West Nile virus disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Clinical characteristics and functional outcomes of West Nile Fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Acute flaccid paralysis and West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Neurologic manifestations and outcome of West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

West Nile virus infection: a new acute paralytic illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

West Nile virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

A structural perspective of the flavivirus life cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

The molecular biology of West Nile Virus: a new invader of the western hemisphere

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Avian virulence and thermostable replication of the North American strain of West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Identification of human hnRNP C1/C2 as a dengue virus NS1-interacting protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Innate and Adaptive Immune Responses Determine Protection against Disseminated Infection by West Nile Encephalitis Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

The in vivo differentiation of strains of yellow fever virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Determination of the intramolecular disulfide bond arrangement and biochemical identification of the glycosylation sites of the nonstructural protein NS1 of Murray Valley encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

The NS1 protein of tick-borne encephalitis virus forms multimeric species upon secretion from the host cell

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Immunopathological mechanisms in dengue and dengue hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

based on heuristic

inferred from DOI database lookup

Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.036

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.09.036

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40311131&oldid=1894988011"